Antimicrobial Agents and Chemotherapy, 1098-6596

Tidskrift

Fler filtreringsmöjligheter
  1. 2019
  2. A protein complex from human milk enhances the activity of antibiotics and drugs against Mycobacterium tuberculosis

    Meikle, V., Mossberg, A-K., Mitra, A., Anders P Hakansson & Niederweis, M., 2019 feb 1, I : Antimicrobial Agents and Chemotherapy. 63, 2, e01846-18.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2018
  4. Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”

    Köser, C. U., Heyckendorf, J., Andres, S., Olaru, I. D., Schön, T., Erik Sturegård, Beckert, P., Schleusener, V., Kohl, T. A., Hillemann, D., Moradigaravand, D., Parkhill, J., Peacock, S. J., Niemann, S., Lange, C. & Merker, M., 2018 aug 1, I : Antimicrobial Agents and Chemotherapy. 62, 8, e00616-18.

    Forskningsoutput: TidskriftsbidragLetter

  5. What is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi-and extensively drug-resistant tuberculosis

    Heyckendorf, J., Andres, S., Köser, C. U., Olaru, I. D., Schön, T., Erik Sturegård, Beckert, P., Schleusener, V., Kohl, T. A., Hillemann, D., Moradigaravand, D., Parkhill, J., Peacock, S. J., Niemann, S., Lange, C. & Merkerb, M., 2018 feb 1, I : Antimicrobial Agents and Chemotherapy. 62, 2, e01550-17.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2017
  7. 2016
  8. Novel engineered peptides of a phage lysin as effective antimicrobials against multidrug-resistant Acinetobacter baumannii

    Thandar, M., Rolf Lood, Winer, B. Y., Deutsch, D. R., Euler, C. W. & Fischetti, V. A., 2016, I : Antimicrobial Agents and Chemotherapy. 60, 5, s. 2971-2979 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2015
  10. Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model

    Rolf Lood, Winer, B. Y., Pelzek, A. J., Diez-Martinez, R., Thandar, M., Euler, C. W., Schuch, R. & Fischetti, V. A., 2015 jan 20, I : Antimicrobial Agents and Chemotherapy. 59, 4, s. 1983-91

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. LTX-109 is a Novel Agent for Nasal Decolonisation of Methicillin Resistant and Sensitive Staphylococcus aureus.

    Anna Nilsson, Håkan Janson, Wold, H., Fugelli, A., Andersson, K., Håkangård, C., Olsson, P. & Olsen, W. M., 2015, I : Antimicrobial Agents and Chemotherapy. 59, 1, s. 145-151

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. 2014
  13. A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia

    Rolf Lood, Raz, A., Molina, H., Euler, C. W. & Fischetti, V. A., 2014 mar 17, I : Antimicrobial Agents and Chemotherapy. 58, 6, s. 3073-84

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Evaluation of intra- and extracellular activity of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosis.

    Davies Forsman, L., Schön, T., Simonsson, U. S. H., Bruchfeld, J., Larsson, M., Juréen, P., Erik Sturegård, Giske, C. G. & Angeby, K., 2014, I : Antimicrobial Agents and Chemotherapy. 58, 12, s. 7557-7559

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2012
  16. Increase of beta-Lactam-Resistant Invasive Haemophilus influenzae in Sweden, 1997 to 2010

    Fredrik Resman, Ristovski, M., Forsgren, A., Kaijser, B., Kronvall, G., Patrik Medstrand, Eva Melander, Inga Odenholt & Kristian Riesbeck, 2012, I : Antimicrobial Agents and Chemotherapy. 56, 8, s. 4408-4415

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing

    Werngren, J., Erik Sturegård, Jureen, P., Angeby, K., Hoffner, S. & Schon, T., 2012, I : Antimicrobial Agents and Chemotherapy. 56, 3, s. 1253-1257

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. 2011
  19. Structure-Activity Studies and Therapeutic Potential of Host Defense Peptides of Human Thrombin

    Kasetty, G., Praveen Papareddy, Kalle, M., Rydengård, V., Mörgelin, M., Albiger, B., Malmsten, M. & Artur Schmidtchen, 2011, I : Antimicrobial Agents and Chemotherapy. 55, 6, s. 2880-2890

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2010
  21. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus

    Daniel, A., Euler, C., Mattias Collin, Chahales, P., Gorelick, K. J. & Fischetti, V. A., 2010 apr 1, I : Antimicrobial Agents and Chemotherapy. 54, 4, s. 1603-1612 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Molecular Epidemiology of Metallo-beta-Lactamase-Producing Pseudomonas aeruginosa Isolates from Norway and Sweden Shows Import of International Clones and Local Clonal Expansion

    Samuelsen, O., Toleman, M. A., Sundsfjord, A., Rydberg, J., Leegaard, T. M., Mats Walder, Lia, A., Ranheim, T. E., Rajendra, Y., Hermansen, N. O., Walsh, T. R. & Giske, C. G., 2010, I : Antimicrobial Agents and Chemotherapy. 54, 1, s. 346-352

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. 2009
  24. Evaluation of Strategies for Improving Proteolytic Resistance of Antimicrobial Peptides by Using Variants of EFK17, an Internal Segment of LL-37

    Stroemstedt, A. A., Pasupuleti, M., Artur Schmidtchen & Malmsten, M., 2009, I : Antimicrobial Agents and Chemotherapy. 53, 2, s. 593-602

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2008
  26. Anti-HIV activity of the small modified amino acid {alpha}-hydroxy glycineamide on in vitro and in vivo HIV-1 capsid assembly and infectivity

    Abdurahman, S., Végvári, Á., Youssefi, M., Levi, M., Höglund, S., Andersson, E., Horal, P., Svennerholm, B., Balzarini, J. & Vahlne, A., 2008, I : Antimicrobial Agents and Chemotherapy. 52, 10, s. 3737-3744

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. 2007
  28. Antileishmanial effect of 3-aminooxy-1-aminopropane is due to polyamine depletion.

    Singh, S., Mukherjee, A., Khomutov, A. R., Lo Persson, Heby, O., Chatterjee, M. & Madhubala, R., 2007, I : Antimicrobial Agents and Chemotherapy. 51, s. 528-534

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Deoxyribonucleoside kinases activate nucleoside antibiotics in severe pathogenic bacteria.

    Sandrini, M., Oonagh Shannon, Clausen, A. R., Lars Björck & Piskur, J., 2007, I : Antimicrobial Agents and Chemotherapy. 51, 8, s. 2726-2732

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. In Vitro Activity of Lipopeptides Pal-Lys-Lys-NH2 and Pal-Lys-Lys Alone and in Combination with Antimicrobial Agents against Multiresistant Gram-positive Cocci.

    Kamysz, W., Silvestri, C., Cirioni, O., Giacometti, A., Licci, A., Vittoria, A. D., Okroj, M. & Scalise, G., 2007, I : Antimicrobial Agents and Chemotherapy. 51, 1, s. 354-358

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile

    Noren, T., Akerlund, T., Marlene Wullt, Burman, L. G. & Unemo, M., 2007, I : Antimicrobial Agents and Chemotherapy. 51, 5, s. 1840-1843

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. 2006
  33. Frequent emergence of resistance in Clostridium difficile during treatment of C-difficile-associated diarrhea with Fusidic acid

    Noren, T., Marlene Wullt, Akerlund, T., Back, E., Inga Odenholt & Burman, L. G., 2006, I : Antimicrobial Agents and Chemotherapy. 50, 9, s. 3028-3032

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37.

    Sigurdardottir, T., Andersson, P., Davoudi, M., Malmsten, M., Artur Schmidtchen & Mikael Bodelsson, 2006, I : Antimicrobial Agents and Chemotherapy. 50, 9, s. 2983-2989

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. 2005
  36. 2004
  37. beta-lactamase-producing nontypeable Haemophilus influenzae fails to protect Streptococcus pneumoniae from amoxicillin during experimental acute otitis media

    Westman, E., Lundin, S., Ann Hermansson & Melhus, Å., 2004, I : Antimicrobial Agents and Chemotherapy. 48, 9, s. 3536-3542

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. 2003
  39. Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacin

    Inga Odenholt, Lowdin, E. & Cars, O., 2003, I : Antimicrobial Agents and Chemotherapy. 47, 10, s. 3352-3356

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Selection of Resistant Streptococcus pneumoniae during Penicillin Treatment In Vitro and in Three Animal Models.

    Knudsen, J. D., Inga Odenholt, Erlendsdottir, H., Gottfredsson, M., Cars, O., Frimodt-Møller, N., Espersen, F., Kristinsson, K. G. & Gudmundsson, S., 2003, I : Antimicrobial Agents and Chemotherapy. 47, 8, s. 2499-2506

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: In vitro kinetic model

    Inga Odenholt, Gustafsson, I., Lowdin, E. & Cars, O., 2003, I : Antimicrobial Agents and Chemotherapy. 47, 2, s. 518-523

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. 2002
  43. Pharmacodynamics of moxifloxacin against Streptococcus pyogenes in an in vitro kinetic model

    Inga Odenholt, Lowdin, E., Gustafsson, I. & Cars, O., 2002, I : Antimicrobial Agents and Chemotherapy. 46, 6, s. 2046-2048

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Tripeptide Interference with Human Immunodeficiency Virus Type 1 Morphogenesis

    Höglund, S., Su, J., Sandin-Reneby, S., Végvári, Á., Hjertén, S., Sintorn, I-M., Foster, H., Wu, Y-P., Nyström, I. & Vahlne, A., 2002, I : Antimicrobial Agents and Chemotherapy. 46, 11, s. 3597-3605

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. 2000
  46. Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB/cA mice

    Wang, X., Willén, R. & Wadström, T., 2000, I : Antimicrobial Agents and Chemotherapy. 44, 9, s. 2452-2457

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. 1998
  48. Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes

    Kristian Riesbeck, Forsgren, A., Henriksson, A. & Anders Bredberg, 1998 aug 1, I : Antimicrobial Agents and Chemotherapy. 42, 8, s. 1923-1930 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. 1997
  50. 1995
  51. CP-115,953 stimulates cytokine production by lymphocytes

    K. Riesbeck & Forsgren, A., 1995 jan 1, I : Antimicrobial Agents and Chemotherapy. 39, 2, s. 476-483

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. 1994
  53. Limited effects of temafloxacin compared with ciprofloxacin on T- lymphocyte function

    Kristian Riesbeck & Forsgren, A., 1994 jan 1, I : Antimicrobial Agents and Chemotherapy. 38, 4, s. 879-882

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  54. 1990
  55. Ciprofloxacin does not inhibit mitochondrial functions but other antiboitics do

    K. Riesbeck, A. Bredberg & Forsgren, A., 1990 jan 1, I : Antimicrobial Agents and Chemotherapy. 34, 1, s. 167-169

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. 1989
  57. In vitro activities of cefcanel and some other cephalosporins against Pasteurella multocida

    Elisabet Holst, Rollof, J. & Miörner, H., 1989, I : Antimicrobial Agents and Chemotherapy. 33, 12, s. 2142-2143

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift